Coronavirus vaccine developers vow diversity in clinical trials | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
June 09, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, JUNE 09, 2023
Coronavirus vaccine developers vow diversity in clinical trials

Coronavirus chronicle

Reuters
21 July, 2020, 08:25 pm
Last modified: 21 July, 2020, 08:30 pm

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • Covax calls for urgent action to close vaccine equity gap
  • US to share Covid vaccine technology, Biden tells global summit
  • Britain approves Valneva's easy-to-store Covid shot
  • More funds incoming from dev partners for vaccine purchase

Coronavirus vaccine developers vow diversity in clinical trials

A group of physicians and scientists last week urged the US government to include Black, Latino and indigenous Americans in the design and implementation of Covid-19 vaccine trials in hopes of building trust among these at-risk populations

Reuters
21 July, 2020, 08:25 pm
Last modified: 21 July, 2020, 08:30 pm
File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo
File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

Drugmakers racing to develop a safe and effective coronavirus vaccine pledged on Tuesday to ensure their larger clinical trials would include diverse sets of volunteers.

In prepared remarks for a US congressional hearing, several companies vowed to include broad representation as they prepare to launch studies with thousands of volunteers in the coming months.

"Ensuring diversity in these trials, including in terms of race, ethnicity, gender, age, and other factors, is a priority in our efforts," Menelas Pangalos, AstraZeneca Plc's executive vice president of biopharmaceutical research & development, said in prepared remarks ahead of the hearing held by the House subcommittee on oversight and investigations.

A group of physicians and scientists last week urged the US government to include Black, Latino and indigenous Americans in the design and implementation of Covid-19 vaccine trials in hopes of building trust among these at-risk populations.

Representatives from Johnson & Johnson, Moderna Inc , Pfizer Inc, and Merck & Co Inc were also set to testify later on Tuesday in the hearing, which is focused on efforts to develop a safe, effective and accessible Covid-19 vaccine.

More than 150 vaccines are in development globally with an aim to help end the global pandemic that has claimed more than 600,000 lives. But whether any will succeed remains far from clear.

Early data from trials of three potential Covid-19 vaccines released on Monday, including a closely watched candidate from AstraZeneca and Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects.

Top News

Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    Inflation roars on
  • The mystique of Serajul Alam Khan
    The mystique of Serajul Alam Khan
  • Italian Ambassador to Bangladesh, Enrico Nunziata. Photo: UNB
    LNG Supply: Italy interested in long-term agreement with Bangladesh, says envoy

MOST VIEWED

  • Covid is no longer global health emergency: WHO
    Covid is no longer global health emergency: WHO
  • Federal police officers stand guard near the house of former Brazilian President Jair Bolsonaro, during a search operation at his home, in Brasilia, Brazil, 3 May, 2023. REUTERS/Adriano Machado
    Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • World Health Organization logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration//File Photo
    Covid here to stay but moving out of emergency phase: WHO
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India reports 12,591 new Covid cases today, 20% more than yesterday
  • People queue up outside a quick test centre to take their coronavirus disease (Covid-19) antigen rapid tests, in Singapore September 21, 2021. Photo :Reuters
    Singapore witnesses new Covid wave: ‘Cases are mostly mild’
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India logs 5,676 new Covid cases, active infections cross 37,000-mark

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • Covax calls for urgent action to close vaccine equity gap
  • US to share Covid vaccine technology, Biden tells global summit
  • Britain approves Valneva's easy-to-store Covid shot
  • More funds incoming from dev partners for vaccine purchase

Features

Yamaha MT-15 V2

Top 3 150-160cc naked sports bikes in Bangladesh

5h | Wheels
Infograph: TBS

Balancing lives and livelihoods: How can South Asia prepare for the next pandemic?

7h | Panorama
Earning more money isn’t exactly a priority for Messi, already one of the world’s richest athletes. Photo: Bloomberg

Why Lionel Messi chose Miami over Riyadh

7h | Panorama
Many stores at the solar wholesale markets are now half full. Or half empty. Photo: Noor-A-Alam

Empty stores and crowded corridors: How the solar market ran out in a week

9h | Panorama

More Videos from TBS

Stats of Europe’s Top 5 League

Stats of Europe’s Top 5 League

1h | TBS SPORTS
13 helpful tips to negotiate about job

13 helpful tips to negotiate about job

1d | TBS Career
Why did Messi turn away from Europe?

Why did Messi turn away from Europe?

1d | TBS SPORTS
Tips to getting sleep on a hot night

Tips to getting sleep on a hot night

9h | TBS Health

Most Read

1
bKash denied permission to pay $4.10 lakh for Argentina football partnership
Banking

bKash denied permission to pay $4.10 lakh for Argentina football partnership

2
Photo: Noor-A-Alam/TBS
Splash

The Night Dhaka did NOT vibe with Anuv Jain

3
Photo: TBS
Energy

2nd unit of Payra power plant to shut down over coal shortage

4
Photo: Screengrab from a video posted by a NSU student
Energy

'Will collapse any moment': NSU teachers, students raise concern after long power outage hit country's largest private uni

5
Digital bank licence requires Tk125cr capital
Banking

Digital bank licence requires Tk125cr capital

6
Photo: Salahuddin Ahmed Paulash/TBS
Energy

LPG price drops by Tk13.42 per kg

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]